Pharma PLI: Maximum of 55 candidates to be chosen

The authorities on Tuesday issued operational pointers for the manufacturing linked incentive scheme for the pharmaceutical trade to reinforce India’s manufacturing capabilities by growing funding and manufacturing within the sector.
The Department of Pharmaceuticals has notified the ‘Production Linked Incentive (PLI) Scheme for Pharmaceuticals, for which the permitted outlay is Rs 15,000 crore, the Ministry of Chemicals and Fertilizers mentioned in an announcement. “The scheme envisages to create global champions out of India who has the potential to grow in size and scale using cutting edge technology and thereby penetrate the global value chains,” the assertion added.
Based on a sequence of consultations with the pharmaceutical trade and stakeholders within the authorities, the operational pointers for the scheme have been ready and issued on June 1. The scheme is now open to purposes from the trade, the ministry mentioned.
The purposes are invited within the three teams primarily based on the Global Manufacturing Revenue of FY 2019-20 of the candidates.